Alvin Lo
About Alvin Lo
Alvin Lo is the Director of Search & Evaluation, Business Development at BeiGene in the San Francisco Bay Area, with extensive experience in the biotech industry and a PhD in Biochemistry from UC Berkeley.
Current Employment at BeiGene
Alvin Lo is currently serving as the Director of Search & Evaluation, Business Development at BeiGene. In this role, he operates out of the San Francisco Bay Area. His responsibilities likely include scouting for strategic partnerships and opportunities in the biotech sector, with a focus on innovation and therapeutic advancement.
Previous Roles in Business Development
Alvin Lo has accumulated significant experience in business development roles at several companies. From 2020 to 2022, he served as Director of Business Development and Portfolio Management at both AmMax Bio., Inc. and LifeMax Laboratories, Inc. He was responsible for guiding business strategies and managing project portfolios in the biotech field.
Experience in Corporate Strategy
Between 2019 and 2020, Alvin Lo worked at Jazz Pharmaceuticals in Corporate Strategy roles. His tenure lasted one year and was based in the San Francisco Bay Area. During this time, he contributed to the company's strategic initiatives, likely involving merger and acquisition activities and the growth of the company's product portfolio.
Academic Background in Biochemistry
Alvin Lo holds a Doctor of Philosophy (Ph.D.) in Comparative Biochemistry from the University of California, Berkeley. Additionally, he earned a Bachelor of Arts (BA) in Molecular Cell Biology from the same institution. His academic background laid a strong foundation for his career in life sciences and business development.
Expertise in the Biotech Industry
With over a decade of professional experience in Cell Biology and Life Sciences, Alvin Lo has developed a deep expertise in multiple therapeutic areas including oncology, inflammation, and rare diseases. His career has been marked by a strong focus on innovation, M&A, and venture capital investing within the biotech industry.